AUG 01, 2019 10:14 AM PDT

Novel Therapy Shows Promise for Acute Migraines

WRITTEN BY: Nouran Amin

In a study published in The New England Journal of Medicine, a novel drug, by the name of rimegepant, was found to eliminate pain and reduce characteristic symptoms of an acute migraine in comparison to over-the counter drugs. The study was carried out by Albert Einstein College of Medicine and Montefiore Health System for a large clinical trial and is now awaiting the approval of rimegepant by the U.S. Food and Drug Administration. "For the first time in nearly three decades, people with migraine not helped by existing medications may have a new option to find relief during attacks," says first author, Richard B. Lipton, M.D.

Migraines are debilitating and currently affect about 12 to 14% of people worldwide. It is neurologic disorder characterized by periodic attacks of head pain along with symptoms ranging from feelings of nausea to sensitivity from light and sound. Most sufferers experience at least one migraine attack per month with more than half left severely impaired during their attacks.

Presently, individuals with migraines likely take triptan medications that work to reduce inflammation and constrict blood vessels. These drugs are not beneficial to everyone and can cause intolerable side effect. However, with the novel drug rimegepant, it opens the door for effective and tolerable treatment options besides triptan. "These results confirm that rimegepant's mechanism of action -- blocking the CGRP pathway -- effectively relieves pain and associated symptoms that occur during acute migraine attacks," said Dr. Lipton. "As someone who has studied CGRP blockers for more than a decade, I'm gratified to see their benefits confirmed in a large-scale clinical trial."

Source: Albert Einstein College of Medicine

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 20, 2020
Drug Discovery & Development
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
SEP 20, 2020
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
Biopharmaceutical company Bristol-Myers Squibb has found that a new drug combination can reduce death rates among those ...
SEP 21, 2020
Drug Discovery & Development
Metformin Does Not Work in All Type 2 Diabetics
SEP 21, 2020
Metformin Does Not Work in All Type 2 Diabetics
Although metformin is the first-line drug for type-2 diabetics, research shows that it is not always effective for all t ...
OCT 03, 2020
Cannabis Sciences
Cannabis Compound Prevents Colon Cancer in Mice
OCT 03, 2020
Cannabis Compound Prevents Colon Cancer in Mice
Second only to skin cancer, colon cancer is the most common cancer diagnosed in both men and women in the US. Now, resea ...
NOV 02, 2020
Drug Discovery & Development
Beetroot Peptide Shows Promise in Treating Inflammatory Diseases
NOV 02, 2020
Beetroot Peptide Shows Promise in Treating Inflammatory Diseases
Researchers from the Medical Univesity of Vienna in Austria have found that a peptide (a small protein molecule) found i ...
NOV 20, 2020
Drug Discovery & Development
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
NOV 20, 2020
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
Researchers from the UK and France have discussed a mechanism of action behind the infamous Toxoplasma gondii  ...
NOV 26, 2020
Drug Discovery & Development
Sestrin Increases the Lifespan of Fruit Flies
NOV 26, 2020
Sestrin Increases the Lifespan of Fruit Flies
Reduced food intake, known as dietary restriction, leads to a longer lifespan in many animals and can improve health in ...
Loading Comments...